Oscar Health (NYSE:OSCR) CAO Victoria Baltrus Sells 958 Shares

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 958 shares of the business’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total value of $30,129.10. Following the transaction, the chief accounting officer owned 213,631 shares in the company, valued at approximately $6,718,694.95. This trade represents a 0.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $32.90 on Wednesday. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.55. The company has a market cap of $10.15 billion, a PE ratio of 23.50, a P/E/G ratio of 0.66 and a beta of 2.37. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The business has a 50-day simple moving average of $30.58 and a two-hundred day simple moving average of $23.01.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. The firm had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The company’s revenue for the quarter was up 70.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.89) earnings per share. As a group, equities analysts expect that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Large investors have recently bought and sold shares of the business. T. Rowe Price Investment Management Inc. grew its holdings in Oscar Health by 11.0% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock valued at $132,461,000 after purchasing an additional 910,320 shares during the period. California State Teachers Retirement System increased its position in shares of Oscar Health by 3,214.2% in the second quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company’s stock valued at $222,543,000 after buying an additional 7,567,600 shares in the last quarter. Morgan Stanley raised its stake in shares of Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after buying an additional 2,043,758 shares during the period. Thrive Capital Management LLC lifted its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares in the last quarter. Finally, BIT Capital GmbH lifted its position in shares of Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after buying an additional 5,227,152 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on OSCR shares. The Goldman Sachs Group reissued a “neutral” rating and issued a $30.00 target price on shares of Oscar Health in a research report on Tuesday, August 11th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Robert W. Baird set a $27.00 price objective on Oscar Health in a report on Friday, August 7th. Wells Fargo & Company lifted their target price on Oscar Health from $20.00 to $27.00 and gave the stock an “equal weight” rating in a report on Thursday, August 13th. Finally, Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $26.22.

Key Oscar Health News

Here are the key news stories impacting Oscar Health this week:

• Neutral Sentiment: Director Mario Schlosser sold 31,422 shares for approximately $988,000 and retained 449,444 shares. Mario Schlosser SEC filing
• Neutral Sentiment: CFO Richard Blackley sold 28,869 shares valued at roughly $908,000, while continuing to own more than 1.04 million shares. Richard Blackley SEC filing
• Neutral Sentiment: Other insiders Adam Mcananey, Janet Liang and Chief Accounting Officer Victoria Baltrus sold approximately $642,000 combined. Each sale was also tied to tax obligations and represented only a modest reduction in their respective holdings. Adam Mcananey SEC filing Janet Liang SEC filing Victoria Baltrus SEC filing

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.